Search Results Search Sort by RelevanceMost Recent Policy Forum Apr 2020 Should Surgeons or Anesthesiologists Manage Perioperative Pain Protocols? Patricia Doerr, MD and Brooke Chidgey, MD Enhanced Recovery After Surgery (ERAS®) protocols vary by surgery type and are compared, clinically and ethically, to traditional protocols. AMA J Ethics. 2020;22(4):E319-324. doi: 10.1001/amajethics.2020.319. Policy Forum Aug 2020 Revisiting the WHO Analgesic Ladder for Surgical Management of Pain Laura Stone McGuire, MD and Konstantin Slavin, MD A 3-step analgesic ladder was introduced in 1986 and needs change. Surgical interventions could reduce opioid use and motivate expansion of current pain management approaches. AMA J Ethics. 2020;22(8):E695-701. doi: 10.1001/amajethics.2020.695. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Policy Forum Jan 2006 What Good Is Hypertension Screening If You Don't Do Anything About It? Christian J. Krautkramer Virtual Mentor. 2006;8(1):42-47. doi: 10.1001/virtualmentor.2006.8.1.pfor1-0601. Policy Forum Jan 2008 Wellness Programs: Legality, Fairness, and Relevance Laura D. Hermer, JD, LLM Virtual Mentor. 2008;10(1):45-48. doi: 10.1001/virtualmentor.2008.10.1.pfor1-0801. Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311. Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Policy Forum Apr 2020 Should Surgeons or Anesthesiologists Manage Perioperative Pain Protocols? Patricia Doerr, MD and Brooke Chidgey, MD Enhanced Recovery After Surgery (ERAS®) protocols vary by surgery type and are compared, clinically and ethically, to traditional protocols. AMA J Ethics. 2020;22(4):E319-324. doi: 10.1001/amajethics.2020.319.
Policy Forum Aug 2020 Revisiting the WHO Analgesic Ladder for Surgical Management of Pain Laura Stone McGuire, MD and Konstantin Slavin, MD A 3-step analgesic ladder was introduced in 1986 and needs change. Surgical interventions could reduce opioid use and motivate expansion of current pain management approaches. AMA J Ethics. 2020;22(8):E695-701. doi: 10.1001/amajethics.2020.695.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Policy Forum Jan 2006 What Good Is Hypertension Screening If You Don't Do Anything About It? Christian J. Krautkramer Virtual Mentor. 2006;8(1):42-47. doi: 10.1001/virtualmentor.2006.8.1.pfor1-0601.
Policy Forum Jan 2008 Wellness Programs: Legality, Fairness, and Relevance Laura D. Hermer, JD, LLM Virtual Mentor. 2008;10(1):45-48. doi: 10.1001/virtualmentor.2008.10.1.pfor1-0801.
Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311.
Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609.